Kimberly-Clark completed its acquisition of Kenvue on Nov. 2, combining the owner of brands including Huggies and Kleenex with the consumer-health company behind brands such as Tylenol and Band-Aid. Kenvue is now a wholly owned subsidiary of Kimberly-Clark, operating as Kenvue LLC.
Kenvue shareholders received a mix of Kimberly-Clark stock and cash, while Kenvue employee equity awards were converted into awards tied to Kimberly-Clark shares.
Key details
- Shareholder consideration: Each eligible Kenvue share was converted into the right to receive 0.14625 shares of Kimberly-Clark common stock plus $3.50 in cash. No interest is payable on the cash portion.
- Stock issued: Kimberly-Clark delivered, or is obligated to deliver, about 281.1 million shares for Kenvue common stock. Holders entitled to fractional Kimberly-Clark shares will receive cash instead.
- Kenvue’s new status: Kenvue became a direct, wholly owned subsidiary of Kimberly-Clark. Its shares were canceled as part of the transaction, and the business now operates through Kenvue LLC.
- Employee awards: Kenvue stock options and restricted and deferred stock units were converted into corresponding Kimberly-Clark awards, generally retaining their vesting conditions. Kenvue performance stock units became time-vesting restricted stock units; their share amounts were based on the greater of target or actual performance measured through the closing.
- Option terms: Converted options carry an adjusted exercise price based on the exchange ratio used to convert the awards.
What changes for investors
Kenvue shareholders have exchanged their direct ownership in Kenvue for a combination of Kimberly-Clark shares and cash. Kimberly-Clark has added Kenvue as a wholly owned business and issued about 281.1 million shares in connection with the acquisition.